American journal of ophthalmology · 2007
Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stein Joshua D, Sloan Frank A, Lee Paul P
Аннотация
PURPOSE: To determine rates of glaucoma medication utilization among glaucoma suspects in the Medicare Current Beneficiary Survey (MCBS) and identify recent utilization patterns for various hypotensive drug classes.
DESIGN: Cohort study.
METHODS: By using MCBS data between 1992 and 2002 merged with Medicare claims data, utilization rates for glaucoma medication classes were calculated for survey participants >/=65 years with suspected glaucoma. Utilization trends over the 11-year period were identified.
RESULTS: Each year, more than 85% of glaucoma suspects used no hypotensive medications. Between 1992 and 2002, utilization rates decreased substantially for beta-blockers and miotics and increased for alpha-agonists, combination beta-blockers-carbonic-anhydrase inhibitors, and prostaglandin analogues.
CONCLUSION: This study identifies recent changes in patterns of glaucoma suspects' use of hypotensive medications by using patient-reported information, thus avoiding reliance on third-party databases. Such trends over time are important to recognize, because they reflect variations in patient care and have economic and clinical implications.
DESIGN: Cohort study.
METHODS: By using MCBS data between 1992 and 2002 merged with Medicare claims data, utilization rates for glaucoma medication classes were calculated for survey participants >/=65 years with suspected glaucoma. Utilization trends over the 11-year period were identified.
RESULTS: Each year, more than 85% of glaucoma suspects used no hypotensive medications. Between 1992 and 2002, utilization rates decreased substantially for beta-blockers and miotics and increased for alpha-agonists, combination beta-blockers-carbonic-anhydrase inhibitors, and prostaglandin analogues.
CONCLUSION: This study identifies recent changes in patterns of glaucoma suspects' use of hypotensive medications by using patient-reported information, thus avoiding reliance on third-party databases. Such trends over time are important to recognize, because they reflect variations in patient care and have economic and clinical implications.